Jeffrey Yordon - Net Worth and Insider Trading
Jeffrey Yordon Net Worth
The estimated net worth of Jeffrey Yordon is at least $15 Million dollars as of 2024-04-25. Jeffrey Yordon is the CEO of Sagent Pharmaceuticals Inc and owns about 669,036 shares of Sagent Pharmaceuticals Inc (SGNT) stock worth over $15 Million. Jeffrey Yordon is also the See Remarks of Athenex Inc and owns about 10,946 shares of Athenex Inc (ATNXQ) stock worth over $166. Details can be seen in Jeffrey Yordon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey Yordon has not made any transactions after 2020-03-12 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey Yordon
Jeffrey Yordon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Yordon owns 2 companies in total, including Athenex Inc (ATNXQ) , and Sagent Pharmaceuticals Inc (SGNT) .
Click here to see the complete history of Jeffrey Yordon’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Yordon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATNXQ | Athenex Inc | 2020-03-12 | See Remarks |
| SGNT | Sagent Pharmaceuticals Inc | 2015-02-27 | director |
Jeffrey Yordon Latest Holdings Summary
Jeffrey Yordon currently owns a total of 2 stocks. Among these stocks, Jeffrey Yordon owns 669,036 shares of Sagent Pharmaceuticals Inc (SGNT) as of September 16, 2013, with a value of $15 Million and a weighting of 100%. Jeffrey Yordon also owns 10,946 shares of Athenex Inc (ATNXQ) as of March 12, 2020, with a value of $166 and a weighting of 0%.
Latest Holdings of Jeffrey Yordon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGNT | Sagent Pharmaceuticals Inc | 2013-09-16 | 669,036 | 21.76 | 14,558,223 |
| ATNXQ | Athenex Inc | 2020-03-12 | 10,946 | 0.02 | 166 |
Holding Weightings of Jeffrey Yordon
Jeffrey Yordon Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Yordon has made a total of 0 transactions in Sagent Pharmaceuticals Inc (SGNT) over the past 5 years. The most-recent trade in Sagent Pharmaceuticals Inc is the sale of 85,813 shares on September 16, 2013, which brought Jeffrey Yordon around $2 Million.
According to the SEC Form 4 filings, Jeffrey Yordon has made a total of 1 transactions in Athenex Inc (ATNXQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Athenex Inc is the acquisition of 500 shares on March 12, 2020, which cost Jeffrey Yordon around $81,400.
Insider Trading History of Jeffrey Yordon
- 1
Jeffrey Yordon Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey Yordon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Yordon is 32.27%. GuruFocus also compares Jeffrey Yordon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Yordon within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey Yordon's insider trading performs compared to the benchmark.
Performance of Jeffrey Yordon
Average Return
-14.73%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.05 | 32.27 | 23.32 | -14.73 | -27.21 | -50.67 |
| Relative Return to S&P 500(%) | 6.04 | 23.38 | 7.02 | -41.21 | -42.17 | -67.47 |
Jeffrey Yordon Ownership Network
Ownership Network List of Jeffrey Yordon
Ownership Network Relation of Jeffrey Yordon
Jeffrey Yordon Owned Company Details
What does Athenex Inc do?
Who are the key executives at Athenex Inc?
Jeffrey Yordon is the See Remarks of Athenex Inc. Other key executives at Athenex Inc include director & CEO and Chairman of the Board Lau Johnson Yiu Nam , Chief Financial Officer Joe Annoni , and See Remarks Timothy Devere Cook .
Athenex Inc (ATNXQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Athenex Inc (ATNXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Athenex Inc (ATNXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Athenex Inc (ATNXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Athenex Inc Insider Transactions
Jeffrey Yordon Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Yordon. Currently GuruFocus does not have mailing address information for Jeffrey Yordon.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
